Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Amnesia-Memory Loss

dichlororibofuranosylbenzimidazole has been researched along with Amnesia-Memory Loss in 3 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Osorio-Gómez, D1
Saldivar-Mares, KS1
Perera-López, A1
McGaugh, JL1
Bermúdez-Rattoni, F1
Igaz, LM1
Vianna, MR1
Medina, JH1
Izquierdo, I1
Romano, A1
Locatelli, F1
Delorenzi, A1
Pedreira, ME1
Maldonado, H1

Other Studies

3 other studies available for dichlororibofuranosylbenzimidazole and Amnesia-Memory Loss

ArticleYear
Early memory consolidation window enables drug induced state-dependent memory.
    Neuropharmacology, 2019, 03-01, Volume: 146

    Topics: Amnesia; Animals; Anisomycin; Dichlororibofuranosylbenzimidazole; Extinction, Psychological; Injecti

2019
Two time periods of hippocampal mRNA synthesis are required for memory consolidation of fear-motivated learning.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Aug-01, Volume: 22, Issue:15

    Topics: Amanitins; Amnesia; Animals; Anisomycin; Avoidance Learning; Catheterization; Dichlororibofuranosylb

2002
Effects of activation and inhibition of cAMP-dependent protein kinase on long-term habituation in the crab Chasmagnathus.
    Brain research, 1996, Sep-30, Volume: 735, Issue:1

    Topics: Amnesia; Animals; Antineoplastic Agents; Brachyura; Brain Chemistry; Conditioning, Psychological; Cy

1996